207 related articles for article (PubMed ID: 34470483)
1. Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack.
Hoshino T; Ishizuka K; Toi S; Mizuno T; Nishimura A; Takahashi S; Wako S; Kitagawa K
Stroke; 2022 Jan; 53(1):79-86. PubMed ID: 34470483
[TBL] [Abstract][Full Text] [Related]
2. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
Sirimarco G; Labreuche J; Bruckert E; Goldstein LB; Fox KM; Rothwell PM; Amarenco P;
Stroke; 2014 May; 45(5):1429-36. PubMed ID: 24736236
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study.
Hoshino T; Mizuno T; Ishizuka K; Takahashi S; Arai S; Toi S; Kitagawa K
Cardiovasc Diabetol; 2022 Nov; 21(1):264. PubMed ID: 36451149
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Hypertriglyceridemia in Patients With Stroke of Atherothrombotic Origin.
Hoshino T; Ishizuka K; Toi S; Mizuno T; Nishimura A; Wako S; Takahashi S; Kitagawa K
Neurology; 2022 Apr; 98(16):e1660-e1669. PubMed ID: 35296551
[TBL] [Abstract][Full Text] [Related]
5. Atherogenic dyslipidemia in patients with transient ischemic attack.
Sirimarco G; Deplanque D; Lavallée PC; Labreuche J; Meseguer E; Cabrejo L; Guidoux C; Olivot JM; Abboud H; Lapergue B; Klein IF; Mazighi M; Touboul PJ; Bruckert E; Amarenco P
Stroke; 2011 Aug; 42(8):2131-7. PubMed ID: 21737806
[TBL] [Abstract][Full Text] [Related]
6. Low-Density Lipoprotein Cholesterol and Risk of Recurrent Vascular Events in Chinese Patients With Ischemic Stroke With and Without Significant Atherosclerosis.
Lau KK; Chua BJ; Ng A; Leung IY; Wong YK; Chan AH; Chiu YK; Chu AX; Leung WCY; Tsang AC; Teo KC; Mak HK
J Am Heart Assoc; 2021 Aug; 10(16):e021855. PubMed ID: 34369170
[TBL] [Abstract][Full Text] [Related]
7. Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke.
Zhao L; Wang R; Song B; Tan S; Gao Y; Fang H; Lu J; Xu Y
Int J Stroke; 2015 Jul; 10(5):752-8. PubMed ID: 25924059
[TBL] [Abstract][Full Text] [Related]
8. Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012.
Saposnik G; Fonarow GC; Pan W; Liang L; Hernandez AF; Schwamm LH; Smith EE;
Stroke; 2014 Nov; 45(11):3343-51. PubMed ID: 25300975
[TBL] [Abstract][Full Text] [Related]
9. Oxidized Low-Density Lipoprotein to High-Density Lipoprotein Ratio Predicts Recurrent Stroke in Minor Stroke or Transient Ischemic Attack.
Wang A; Li S; Zhang N; Dai L; Zuo Y; Wang Y; Meng X; Wang Y
Stroke; 2018 Nov; 49(11):2637-2642. PubMed ID: 30355199
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
[TBL] [Abstract][Full Text] [Related]
11. Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study.
Lavallée PC; Charles H; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Labreuche J; Molina C; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut É; Wong LKS; Amarenco P;
Lancet Neurol; 2023 Apr; 22(4):320-329. PubMed ID: 36931807
[TBL] [Abstract][Full Text] [Related]
12. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
13. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
[TBL] [Abstract][Full Text] [Related]
14. More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke.
Amarenco P; Lavallée PC; Kim JS; Labreuche J; Charles H; Giroud M; Lee BC; Mahagne MH; Meseguer E; Nighoghossian N; Steg PG; Vicaut É; Bruckert E;
Stroke; 2023 Aug; 54(8):1993-2001. PubMed ID: 37376989
[TBL] [Abstract][Full Text] [Related]
15. What Proportion of Patients Admitted with Stroke or Transient Ischemic Attack May Be Suitable for Newer Cholesterol-Lowering Treatment?
Alakbarzade V; Pereira AC
J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104457. PubMed ID: 31732461
[TBL] [Abstract][Full Text] [Related]
16. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
17. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
[TBL] [Abstract][Full Text] [Related]
18. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).
Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
Stroke; 2018 Apr; 49(4):865-871. PubMed ID: 29511130
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia Increases Vascular Risk in Stroke Patients with Chronic Kidney Disease.
Mizuno T; Hoshino T; Ishizuka K; Toi S; Takahashi S; Wako S; Arai S; Kitagawa K
J Atheroscler Thromb; 2023 Sep; 30(9):1198-1209. PubMed ID: 36436876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
